Cargando…

Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients

Purpose: To evaluate long-term structural and functional changes that happen to the optic nerve and retina following ranibizumab (Lucentis) injections in diabetic macular edema (DME) patients. Methods: Patients with clinically significant DME requiring anti-VEGF injections underwent pre-injection ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filek, Richard, Hooper, Phil, Sheidow, Tom G, Gonder, John, Chakrabarti, Subrata, Hutnik, Cindy ML
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611706/ https://www.ncbi.nlm.nih.gov/pubmed/31303747 http://dx.doi.org/10.2147/OPTH.S199758

Ejemplares similares

Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture
por: Filek, Richard, et al.
Publicado: (2019)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

Impact of anti-VEGF therapy on distinctive retina layers in patients with macular edema secondary to branch retinal vein occlusion
por: Wang, Hui, et al.
Publicado: (2023)

Vitreomacular interface after anti-VEGF injections in diabetic macular edema
por: Veloso, Carlos E., et al.
Publicado: (2021)

Optical Coherence Tomography Angiography of Macular Perfusion Changes after Anti-VEGF Therapy for Diabetic Macular Edema: A Systematic Review
por: Elnahry, Ayman G., et al.
Publicado: (2021)

Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study
por: Kulikov, Alexei N, et al.
Publicado: (2017)

Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema
por: Schreur, Vivian, et al.
Publicado: (2018)

Outer retinal tubulation in diabetic macular edema following anti-VEGF treatment
por: Al-Halafi, Ali M
Publicado: (2015)

Dexamethasone Implant in Patients with Diabetic Macular Edema Resistant to Anti-VEGF Therapy
por: Nalçacı, Serhad, et al.
Publicado: (2019)

Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
por: Distefano, Laura N., et al.
Publicado: (2017)

Glycemic Control after Initiation of Anti-VEGF Treatment for Diabetic Macular Edema
por: Oshima, Hideyuki, et al.
Publicado: (2022)

Diabetic macular edema: it is more than just VEGF
por: Singer, Michael A., et al.
Publicado: (2016)

Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies
por: Ding, Xuefei, et al.
Publicado: (2022)

Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
por: Garoon, Robert B., et al.
Publicado: (2016)

Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
por: Mira, Filipe, et al.
Publicado: (2017)

Foveal Microvascular Integrity Association With Anti-VEGF Treatment Response for Diabetic Macular Edema
por: Huang, Wei-Hsuan, et al.
Publicado: (2021)

Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
por: Gonder, John R., et al.
Publicado: (2014)

Correlation of photoreceptor damage with anti-retina antibodies level in aqueous humor in macular edema patients
por: Han, Xinyao, et al.
Publicado: (2022)

Anti-VEGF Therapy and the Retina: An Update
por: Tah, Vikas, et al.
Publicado: (2015)

Impression cytology implicates cell autophagy in aqueous deficiency dry eye
por: Lin, Tony, et al.
Publicado: (2017)

Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review
por: Wang, Patrick, et al.
Publicado: (2022)

Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Characteristics of diabetic macular edema patients refractory to anti-VEGF treatments and a dexamethasone implant
por: Choi, Moon Young, et al.
Publicado: (2019)

Factors Affecting a Short-Term Response to Anti-VEGF Therapy in Diabetic Macular Edema
por: Usui-Ouchi, Ayumi, et al.
Publicado: (2021)

miRNA Levels as a Biomarker for Anti-VEGF Response in Patients with Diabetic Macular Edema
por: Vader, Maartje J. C., et al.
Publicado: (2021)

Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
por: Zhang, Ying, et al.
Publicado: (2022)

Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain
por: Fernández-Vigo, José Ignacio, et al.
Publicado: (2022)

Regional Variety of Reduction in Retinal Thickness of Diabetic Macular Edema after Anti-VEGF Treatment
por: Yamada, Yutaka, et al.
Publicado: (2022)

Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema
por: Uwimana, Alexandre, et al.
Publicado: (2022)

The role of serum metrics in anti- VEGF treatment for macular edema induced by retinal vein occlusion
por: Wang, Yun-Chang, et al.
Publicado: (2023)

Anti-VEGF Treatment of Diabetic Macular Edema in Denmark: Incidence, Burden of Therapy, and Forecasting Analyses
por: Subhi, Yousif, et al.
Publicado: (2023)

Relationship Between Final Visual Acuity and Optical Coherence Tomography Findings in Patients with Diabetic Macular Edema Undergoing Anti-VEGF Therapy
por: Eraslan, Seher, et al.
Publicado: (2020)

Combination of Navigated Macular Laser Photocoagulation and Anti-VEGF Therapy: Precise Treatment for Macular Edema under Dry Retinal Conditions
por: Boiko, Ernest V., et al.
Publicado: (2017)

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
por: Sorour, Osama A., et al.
Publicado: (2020)

Correction: Aqueous humor cytokine levels in patients with diabetic macular edema refractory to anti-VEGF treatment
por: Kwon, Jin-woo, et al.
Publicado: (2018)

Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
por: Ruiz-Moreno, J. M., et al.
Publicado: (2020)

Anti-VEGF Treatment of Diabetic Macular Edema: Two-Year Visual Outcomes in Routine Clinical Practice
por: Urbančič, Mojca, et al.
Publicado: (2020)

Effect of Alternate Treatment with Intravitreal Corticosteroid and Anti-VEGF for Macular Edema Secondary to Retinal Vein Occlusion
por: Bae, Young Hwan, et al.
Publicado: (2021)

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
por: Ahmedalgabri, Rayan Hamza Mohammed, et al.
Publicado: (2022)

Synergistic Effect of Combined Sub-Tenon Triamcinolone and Intravitreal Anti-VEGF Therapy for Uveitic Macular Edema
por: Lin, Dan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fdcv1tiui00aebj6sli03ng5g